Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Assets (2016 - 2025)

Dare Bioscience (DARE) has disclosed Current Assets for 11 consecutive years, with $25.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets rose 67.29% year-over-year to $25.0 million, compared with a TTM value of $25.0 million through Sep 2025, up 67.29%, and an annual FY2024 reading of $18.4 million, up 5.15% over the prior year.
  • Current Assets was $25.0 million for Q3 2025 at Dare Bioscience, up from $6.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $55.3 million in Q4 2021 and bottomed at $6.6 million in Q2 2025.
  • Average Current Assets over 5 years is $27.2 million, with a median of $22.2 million recorded in 2023.
  • The sharpest move saw Current Assets skyrocketed 691.76% in 2021, then crashed 68.3% in 2025.
  • Year by year, Current Assets stood at $55.3 million in 2021, then decreased by 22.17% to $43.0 million in 2022, then crashed by 59.24% to $17.5 million in 2023, then rose by 5.15% to $18.4 million in 2024, then skyrocketed by 35.54% to $25.0 million in 2025.
  • Business Quant data shows Current Assets for DARE at $25.0 million in Q3 2025, $6.6 million in Q2 2025, and $11.8 million in Q1 2025.